Trending PR Campaigns
AI-Powered Clinical Trial Savings Study
Medable worked with the Tufts Center for the Study of Drug Development to quantify what its AI clinical-monitoring agent could save in cancer-drug trials. The resulting study claimed the technology could cut around 10 weeks and up to $5.6 million from late-stage trials, giving the brand a data-led hook for healthcare and business coverage.
Why it worked: It packaged third-party quantified ROI (10 weeks, $5.6M) from a credible academic model, turning vague AI hype into hard, exclusive numbers.
The lesson: Consider commissioning an independent model to quantify time or cost saved, then pitch the clearest before/after dollar and weeks headline.
Coverage over time
How this story spread across the media
| Publication | Headline | Date |
|---|---|---|
| axios.com | AI brings savings to clinical trials: study | Wednesday 12th August, 2026 |
| ibtimes.com | AI Could Cut 10 Weeks From Cancer Trials. Drugmakers Could Save Millions. | IBTimes | Thursday 13th August, 2026 |
| clinicaltrialsarena.com | AI can deliver gains of $21m per drug development programme, study finds | Thursday 13th August, 2026 |
| genengnews.com | Financial Value of AI Agents in Drug Development | Thursday 13th August, 2026 |